elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38979882-84AB628D-073B-4F46-B953-CD2CF86EB45E
Q38979882-84AB628D-073B-4F46-B953-CD2CF86EB45E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38979882-84AB628D-073B-4F46-B953-CD2CF86EB45E
Sulfatinib, a novel kinase inhibitor, in patients with advanced solid tumors: results from a phase I study
P1433
Q38979882-84AB628D-073B-4F46-B953-CD2CF86EB45E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38979882-84AB628D-073B-4F46-B953-CD2CF86EB45E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1acafb72a9c7292618797055bb8093bacc5eaa73
P1433
Oncotarget